PRNP and variant Creutzfeldt-Jakob disease: Despite all the remaining difficulties, the results obtained so far by two different methodologies (PMCA as presented here and the abnormal PrP capture), and the rapid progress of QuIC derived technologies, allow potential new possibilities for vCJD screening and the prevention of its iatrogenic transmission.